Lupin logo

LUPIN - Lupin News Story

₹1186.9 -2.3  -0.2%

Last Trade - 11:28am

Sector
Healthcare
Size
Large Cap
Market Cap £5.20bn
Enterprise Value £5.28bn
Revenue £1.46bn
Position in Universe 83rd / 3114

Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes drug

Tue 3rd December, 2019 11:34am
Dec 3 (Reuters) - Three pharmacy chains, including Walgreens
Boots Alliance  WBA.O , have filed a lawsuit against drugmakers
Bausch Health Inc  BHC.TO , Assertio Therapeutics  ASRT.O  and
Lupin Ltd  LUPN.NS , seeking damages for overcharging for
Bausch's diabetes drug Glumetza. 
    The lawsuit, filed on Monday, alleges that Assertio and
Lupin struck a deal with units of Bausch to delay the entry of
their generic versions of Glumetza and allowed the companies to
"maintain a monopoly" in the sale of the branded drug and its
generic copies.  
    Bausch, Assertio and Lupin did not immediately respond to
Reuters' request for comment. 
    Albertson Companies Inc  ABS.N  and Kroger Inc  KR.N  were
among the other defendants.
    

 (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini
Ganguli)
 ((Manas.Mishra@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 806749 8325;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.